SMTL ID : 6lkd.1

in meso full-length rat KMO in complex with a pyrazoyl benzoic acid inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

homo-dimer

Ligands

2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)

FAD.1: 33 residues within 4Å: Chain A: I.16, G.17, G.19, L.20, V.21, G.22, Y.39, E.40, A.41, R.42, R.54, S.55, L.58, A.59, R.113, H.136, K.137, L.138, C.168, D.169, G.170, T.174, Y.196, G.305, D.306, P.313, G.316, Q.317, G.318, M.319, N.320 Ligands: EGO.2, CL.4 23 PLIP interactions: 23 interactions with chain A Hydrophobic interactions: A:Y.196, A:P.313, A:P.313 Hydrogen bonds: A:L.20, A:V.21, A:G.22, A:A.41, A:R.42, A:R.42, A:R.54, A:S.55, A:S.55, A:A.59, A:A.59, A:R.113, A:L.138, A:L.138, A:D.306, A:G.318, A:M.319, A:N.320, A:N.320 Salt bridges: A:R.113 FAD.5: 32 residues within 4Å: Chain B: I.16, G.17, G.19, L.20, V.21, G.22, Y.39, E.40, A.41, R.42, S.55, L.58, A.59, R.113, H.136, K.137, L.138, C.168, D.169, G.170, T.174, Y.196, G.305, D.306, P.313, G.316, Q.317, G.318, M.319, N.320 Ligands: EGO.6, CL.8 22 PLIP interactions: 22 interactions with chain B Hydrophobic interactions: B:Y.196, B:P.313 Hydrogen bonds: B:G.17, B:L.20, B:V.21, B:G.22, B:A.41, B:R.42, B:R.42, B:S.55, B:S.55, B:A.59, B:A.59, B:R.113, B:L.138, B:L.138, B:D.306, B:G.318, B:M.319, B:N.320, B:N.320 Salt bridges: B:R.113

2 x EGO: 5-[5-(4-chloranyl-3-fluoranyl-phenyl)-4-methyl-pyrazol-1-yl]-2-phenylmethoxy-benzoic acid(Non-covalent)

EGO.2: 19 residues within 4Å: Chain A: R.87, Y.101, L.215, I.217, M.224, I.226, F.240, P.313, F.314, F.315, G.316, N.365, M.369, V.373, F.378, Q.381, R.382, Y.400 Ligands: FAD.1 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.215, A:F.240, A:V.373, A:F.378, A:Q.381, A:Y.400 Hydrogen bonds: A:Y.101, A:Y.101, A:N.365, A:R.382 Salt bridges: A:R.87, A:R.382 EGO.6: 19 residues within 4Å: Chain B: A.59, R.87, Y.101, L.215, I.217, I.226, F.240, P.313, F.314, F.315, G.316, N.365, M.369, V.373, F.378, Q.381, R.382, Y.400 Ligands: FAD.5 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:L.215, B:I.226, B:I.226, B:F.240, B:V.373, B:F.378, B:Q.381, B:Y.400 Hydrogen bonds: B:Y.101, B:Y.101, B:N.365 Salt bridges: B:R.87, B:R.382

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.3: 8 residues within 4Å: Chain A: R.87, P.100, Y.101, G.102, K.386, P.398, Y.400, T.401 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:P.100, A:G.102, A:T.401 Salt bridges: A:R.87, A:K.386 SO4.7: 9 residues within 4Å: Chain B: R.87, P.100, Y.101, G.102, R.382, K.386, P.398, Y.400, T.401 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:P.100, B:G.102, B:R.382, B:T.401 Salt bridges: B:R.87, B:K.386

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.4: 4 residues within 4Å: Chain A: P.313, Q.317, G.318 Ligands: FAD.1 Ligand excluded by PLIP CL.8: 5 residues within 4Å: Chain B: I.311, P.313, Q.317, G.318 Ligands: FAD.5 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mimasu, S. et al., Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition. Commun Biol (2021)

Release Date

2020-12-23

Peptides

Kynurenine 3-monooxygenase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Kynurenine 3-monooxygenase

Related Entries With Identical Sequence